Zum Inhalt

Annals of Hematology

Ausgabe 5/2025

Inhalt (49 Artikel)

Alemtuzumab for haematological malignancies

  • Open Access
  • Review

Ning An, Kangqi Bian, Chunrui Li

Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis

  • Open Access
  • Review

Berkay Kilic, Efe Sacin, Muhammet Kadir Tanin, Ozgur Can Kilinc, Serdal Ugurlu

Impact of BCOR/BCORL1 mutation on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients

  • Open Access
  • Review

YunXia Zhou, Haixiao Zhang, Xinhui Zheng, Rongli Zhang, Xin Chen, Qiaoling Ma, Donglin Yang, Jialin Wei, Aiming Pang, Yi He, Sizhou Feng, Mingzhe Han, Weihua Zhai, Erlie Jiang

Efficacy and safety analysis of China’s first 10% IVIg (RonsenGlob) therapy in treating adult ITP

  • Open Access
  • Research

Lijun Fang, Ting Sun, Hu Zhou, Guitao Jie, Jiaping Fu, Enqin Yang, Zeping Zhou, Ligen Liu, Jingyu Zhang, Shenxian Qian, Yun Chen, Ling Liu, Jian Gu, Fanliang Kong, Ruibin Huang, Yunfei Chen, Lei Zhang

Genetic polymorphism of novel SNP rs5006884 in OR51B6 and SNP rs4499252 in AHSP among transfusion-dependent and non-transfusion-dependent β-thalassemia/Hb E patients in Thailand: a multivariate analysis of clinical and genetic polymorphism

  • Open Access
  • Research

Chidchanok Mahabhol, Lalana Yothindamrongkul, Nicha Nuntanajaroenkul, Purima Nawasod, Wanicha Tepakhan, Rossarin Karnpean, Panjarat Sowithayasakul, Nisa Makruasi, Therdkiat Trongwongsa, Wittaya Jomoui

Clinical characteristics and prognostic factors in patients with fever of unknown origin who developed secondary haemophagocytic lymphohistiocytosis

  • Open Access
  • Research

Zhe Zhou, Guanmin Yuan, Yang Li, Haocheng Zhang, Shenglei Yu, Lingyun Shao, Jingwen Ai, Wenhong Zhang

Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome

  • Open Access
  • Research

Young Dai Kwon, Kyung Taek Hong, Juyeon Lee, Yoon Sunwoo, Yeseul Kim, Sung Im Cho, Hyun Jin Park, Bo Kyung Kim, Jee-Soo Lee, Jung Yoon Choi, Moon-Woo Seong, Hyoung Jin Kang

Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia

  • Open Access
  • Research

Anna Turkina, Olga Vinogradova, Elza Lomaia, Evgeniya Shatokhina, Oleg Shukhov, Ekaterina Chelysheva, Dzhariyat Shikhbabaeva, Irina Nemchenko, Anna Petrova, Anastasiya Bykova, Nadiya Siordiya, Vasily Shuvaev, Ilya Mikhailov, Fedor Novikov, Veronika Shulgina, Andreas Hochhaus, Oliver Ottmann, Jorge Cortes, Robert Peter Gale, Ghermes Chilov

Selective efficacy of venetoclax in unfit patients with acute myeloid leukemia with myelodysplasia-related gene mutations under low-intensity therapy

  • Open Access
  • Research

Jinya Lin, Xiupu Liu, Shuangwei Ying, Yuanyuan Zhu, Weijia Huang, Weiyan Zheng, Xiujin Ye, Jimin Shi, Yi Luo, Jingsong He, Zhen Cai, Yi Zhao, Wenjun Wu, Donghua He, Xiaoyan Han, Gaofeng Zheng, Yanmin Zhao, Yongxian Hu, He Huang, Jie Sun

Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study

  • Open Access
  • Research

Luana Fianchi, Alfonso Piciocchi, Fabio Guolo, Francesco Marchesi, Giovanni Marsili, Chiara Cattaneo, Michele Gottardi, Francesco Restuccia, Anna Candoni, Elettra Ortu La Barbera, Rita Fazzi, Crescenza Pasciolla, Olimpia Finizio, Nicola Fracchiolla, Mario Delia, Federica Lessi, Michela Dargenio, Valentina Bonuomo, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Picardi, Claudia Basilico, Monica Piedimonte, Paola Minetto, Patrizia Chiusolo, Lucia Prezioso, Caterina Buquicchio, Lorella Melillo, Daniele Zama, Francesca Farina, Valentina Mancini, Michela Rondoni, Alessandro Busca, Livio Pagano

Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia

  • Open Access
  • Research

Vincenzo Sammartano, Anna Sicuranza, Paola Pacelli, Elena Bestoso, Adele Santoni, Corrado Zuanelli Brambilla, Marzia Defina, Alessandra Cartocci, Donatella Raspadori, Monica Bocchia

Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis

  • Open Access
  • Research

Olga Morath, Jenny Rinke, Annabell Walter, Carl Crodel, Manja Meggendorfer, Constance Baer, Andreas Hochhaus, Thomas Ernst

Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS study

  • Open Access
  • Research

Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, Chor Sang Chim, Robin Carson, Rui Liu, Man Zhao, Xi Chen, Canchan Cui, Jian Hou, Jianxiang Wang

Real-world data on the use of subcutaneous daratumumab plus bortezomib, thalidomide, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma

  • Open Access
  • Research

Vania Hungria, Fernanda Lemos Moura, Abel Costa, Eduardo Flávio Oliveira Ribeiro, Paulo Soares, Juliana Souza Lima, Lisa Aquaroni Ricci, Celso Arrais-Rodrigues, Fabio Moore Nucci, Marinus de Moraes Lima, Roberto Jose Pessoa de Magalhães Filho, Amitabha Bhaumik, Trilok Parekh, Fredrik Borgsten, Robin Carson, Damila C. Trufelli, Edvan de Queiroz Crusoe

Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myeloma

  • Open Access
  • Research

Julius C. Enssle, Tonio Brinkschmidt, Ralf Dürrwald, Sebastian Wolf, David Zurmeyer, Björn Steffen, Evelyn Ullrich, Thomas Oellerich, Hubert Serve, Ivana von Metzler

Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL

  • Open Access
  • Research

Yuhong Ren, Hui Tan, Jingli Zhuang, Luya Cheng, Ling Yuan, Lili Ji, Yang Ke, Xuejiao Zhang, Zhixiang Cheng, Jing Li, Peng Liu

Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial

  • Open Access
  • Research

Ulrich Dührsen, Gabriele Prange-Krex, Regina Moeller, Harald Held, Gerhard Heil, Andreas Schwarzer, Stefan Mahlmann, Ariane Dienst, Matthias Sandmann, Georg Maschmeyer, Jochen Schütte, Dennis Hahn, Michael Heike, Michael Nonnemacher, Christine Hanoun, Andreas Hüttmann

Identification of molecular clusters and a risk prognosis model for diffuse large B-cell lymphoma based on lactate metabolism-related genes

  • Open Access
  • Research

Jie Zhang, Ting Gao, Shan Chen, Shuang Wu, Yong Mao, Dongyan Cai, Tingxun Lu

Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors

  • Open Access
  • Research

Manon Garcia, Carolyne Croizier, Grégory Lazarian, Anne Quinquenel, Thomas Tassin, Céline Bourgne, Olivier Tournilhac, Jacques-Olivier Bay, Marc G. Berger, Andréi Tchirkov, Lauren Véronèse, Romain Guièze

Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis type

  • Open Access
  • Research

Hisayuki Yokoyama, Shigeo Fuji, Makoto Murata, Masahiro Hirayama, Atsushi Wake, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Satoshi Takahashi, Noriko Doki, Yumiko Maruyama, Kazuya Ishiwata, Yasufumi Uehara, Tetsuya Nishida, Masashi Sawa, Toshiro Kawakita, Tetsuya Eto, Fumihiko Ishimaru, Koji Kato, Tatsuo Ichinohe, Yoshiko Atsuta, Seitaro Terakura, Satoko Morishima

Optimising survivorship post-BMT: healthcare professionals’ perceptions of long-term care

  • Open Access
  • Research

Gemma McErlean, Christine Ashley, Anisha Pradhan, Vanessa Yenson, Ian Kerridge, Elizabeth Halcomb

Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry

  • Open Access
  • Research

Anthea Storck, Gernot Beutel, Matthias Kochanek, Peter Schellongowski, Thomas Staudinger, Nina Buchtele, Julia Cserna, Nicole Brueder, Catherina Lueck, Tobias Liebregts, Asterios Tzalavras, Jakob Hammersen, Frank Kroschinsky, Randolf Forkert, Michael G. Kiehl, Michael von Bergwelt-Baildon, Judit Grans-Sibel, Franziska Bach, Jorge Garcia Borrega, Jan-Hendrik Naendrup, Alexander Shimabukuro-Vornhagen, Dennis A. Eichenauer, Boris Böll

Understanding gut Microbiome changes in Korean children, adolescents, and young adults with hematologic malignancies

  • Open Access
  • Research

Meerim Park, Jongheon Jung, Jun Ah Lee, Eunyoung Lee, Hyewon Lee, Hyeon Seok Eom, Hyeon Jin Park

Venous thromboembolic risk in hematological hospitalized patients: a retrospective study

  • Open Access
  • Research

Stefano Cordella, Valeria Coluccio, Riccardo Cuoghi Costantini, Roberto D’Amico, Mario Luppi, Marco Marietta

Radiotherapy alone with curative intent in a case of limited-stage extranodal NK/T-cell lymphoma nasal type: a case report and review of the literature

  • Open Access
  • Case Report

Biancamaria Mandelli, Donatella Caivano, Antonella Fontana, Natalia Cenfra, Sergio Mecarocci, Maristella Marrocco, David Fanciullo, Roberta Mazzarella, Martina Lorenzon, Giada Pacitto, Alessandro Pulsoni

Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs

  • Open Access
  • Case Report

Ruth Stuckey, Laura Navarrete Bullón, Asunción Borrero Borrego, Violeta Vidal Ballester, Carlos Rodríguez-Medina, Alejandro Morales Curbelo, Leslie González Pinedo, Melissa Torres Ochando, Alvaro Veiga Vaz, María del Mar Perera, Cristina Bilbao-Sieyro, Juan Francisco López Rodríguez, Adrián Segura-Díaz, María Teresa Gómez-Casares

From severe aplastic anemia with TERT variant to Wilson disease - associations or not

  • Open Access
  • Case Report

Tong Chen, Jia Song, Limin Xing, Jin Chen, Xifeng Dong, Lijuan Li, Junfeng Yang, Wentian Liu, Zonghong Shao, Rong Fu

Paraneoplastic leukocytoclastic vasculitis mimicking ulcus cruris as rare initial manifestation of smoldering myeloma IgG kappa

  • Open Access
  • Case Report

Christina Brummer, Kirsten Utpatel, Sebastian Geis, Sebastian Haferkamp, Andreas Brosig, Markus Herrmann, Chiara Arnreich, Joachim Hahn, Tobias Pukrop, Wolfgang Herr, Sabine Gaerditz

An unexpected find of multifocal extranodal marginal zone lymphoma

  • Open Access
  • Case Report

Glenn Van den Bosch, M. Develter, J. Willemse, J. Boes, K. Somers, U. Douven

First-line treatment of TAFRO syndrome with rituximab: a case report and literature review

  • Open Access
  • Case Report

Salar Servati, Ida Mohammadi, Shahryar Rajai Firouzabadi

A rare case of type 2A von Willebrand disease with compound heterozygous mutation

  • Open Access
  • Case Report

Li-jing Wang, Qi Gao, Bo Pang, Tao Wu, Xuyang Zhang, Hansheng Fang, Haidan Chen, Huili Cai

A case series of B-Lymphoblastic lymphoma with C-MYC rearrangement in children: diagnostic and therapeutic challenges

  • Open Access
  • Case Report

Xueliang Yang, Yanlong Duan, Chunju Zhou, Ningning Zhang, Xueqing Bai, Ling Jin, Shuang Huang, Meng Zhang

Multisystem Langerhans cell histiocytosis in a pediatric patient: a rare case report with literature review and future directions

  • Open Access
  • Case Report

Hamdah Hanifa, Sakhr Alshwayyat, Carolin Maksoud, Alhareth M. Amro, Mustafa Alshwayyat, Tala Abdulsalam Alshwayyat, Mesk Alkhatib, Basil Alsaleh, Ramez M. Odat, Ammar Ahmad

What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?

  • Open Access
  • Correspondence

Katherine J. Taylor, Susanne Singer, Saskia Langemeijer, Richard J. Kelly, Louise Arnold, Jens Panse, Christopher J. Patriquin, Jun-ichi Nishimura, Maria Piggin, Pascale O Burmester

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Podcast

Depression: Die Zeit bis zum Therapieplatz sinnvoll nutzen

Die Zahl der diagnostizierten Depressionen steigt – gleichzeitig fehlen flächendeckend Therapieplätze. Für Betroffene ist die Hausarztpraxis eine erste Anlaufstelle. Doch wie kann dort der passende Raum entstehen? Allgemeinmedizinerin Prof. Dr. med. Anne Simmenroth und Psychologin Maike Krauthausen berichten, wie niederschwellig Hilfe angeboten werden kann.

Zeitschrift für Allgemeinmedizin, DEGAM

FLT3-Hemmung wirkt auch bei FLT3-ITD-negativer AML

Ergebnisse der Phase-II-Studie QUIWI nach längerem Follow-up sprechen weiter dafür, dass auch Personen mit neu diagnostizierter FLT3-ITD-negativer AML von einer Erweiterung der Standardchemotherapie um den zielgerichteten Wirkstoff Quizartinib profitieren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, ZFA TALKS - Depression/© (M) seb_ra / Getty Images / iStock (Symbolbild mit Fotomodell) Logo: Springer Medizin Verlag GmbH, Histopathologischer Befund bei akuter myeloischer Leukämie/© National Cancer Institute/cancer.gov